On July 10, 2023, Perspective Therapeutics, Inc. terminated the employment of Jennifer Streeter, the Companyâs Chief Operating Officer, effective immediately. Subject to Ms. Streeterâs compliance with the separation conditions set out in that certain Employment Agreement, effective as of May 24, 2021, by and between the Company and Ms. Streeter including the execution and non-revocation of a release, Ms. Streeter will be eligible to receive the severance and other benefits set out in Section 5(b) of the Streeter Employment Agreement applicable to a termination without cause.
Perspective Therapeutics, Inc.
Equities
CATX
US46489V1044
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.51 USD | +1.34% | -1.31% | +275.62% |
15/05 | Transcript : Perspective Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10:00 AM | |
15/05 | Perspective Therapeutics Swings to Loss in Q1, Revenue Rises | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+275.62% | 886M | |
-5.31% | 181B | |
-1.21% | 108B | |
-5.53% | 66.57B | |
+1.22% | 49.95B | |
+7.03% | 43.84B | |
+4.91% | 41.71B | |
+21.96% | 31.59B | |
+14.45% | 25.3B | |
-4.81% | 23.83B |
- Stock Market
- Equities
- CATX Stock
- News Perspective Therapeutics, Inc.
- Perspective Therapeutics, Inc. Announces Termination of Jennifer Streeter as Chief Operating Officer